New Vaccine Targets H5N1 Transmission in Dairy Cattle
In response to rising bird flu outbreaks in dairy cattle, scientists have created an mRNA vaccine that may protect calves from the H5N1 virus. This early-stage vaccine is a major step toward addressing viral transmission within the dairy sector.
Developed by researchers at the University of Pennsylvania and the USDA, the vaccine has been tested in young calves to evaluate its effectiveness in preventing infection through contaminated milk. The findings are posted on bioRxiv, pending peer review.
The United States Department of Agriculture reported that 17 dairy herds in Idaho tested positive for bird flu in May—the highest number among all states. The situation has increased concerns about both livestock health and food safety.
Although adult cattle have not yet been tested with the vaccine, researchers are hopeful. The experimental vaccine works by teaching the immune system to recognize the H5N1 virus early, preventing illness in young animals.
Dr. David Pate commented on the value of the study, saying, “It's not a total solution, that the more we learn about these vaccines and how we can adapt them to stop these transmissions is going to make our food sources safer.”
This innovative vaccine uses mRNA technology, similar to COVID-19 vaccines, allowing rapid updates and better adaptability to evolving threats. If successful, this method could become a new standard for protecting livestock from emerging diseases.
Despite these promising developments, a setback occurred last week when national plans to produce new human flu vaccines, including those for avian flu, were canceled. This places even more importance on ongoing livestock vaccine research.
As bird flu continues to affect farms across the country, new tools like this mRNA vaccine may help reduce risks and strengthen the agricultural economy. More trials and support are needed to bring these solutions to farms nationwide.